Fair value (multi-method)
Four independent methods triangulate what ZBH is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$41.71
Method range
$41.71 – $200.45
median $70.95
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $41.71 | -52.23% |
| Exit multiple | $200.45 | +129.53% |
| Analyst target | $96.33 | +10.31% |
| Graham number | $45.57 | -47.82% |
- Forward DCF$41.71
- Exit multiple$200.45
- Analyst target$96.33
- Graham number$45.57
Stock price
$87.33
FCF / share (TTM)
$1.66
3Y FCF CAGR
3.7%
Fair value @ hist. growth
$42.50
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
12.7%
per year over your projection horizon
Margin of safety -105.5% vs hist-growth DCF
Historical 3Y CAGR
3.7%
Your model implies
12.7%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at 4% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 8.6% | 7.1% | 5.4% | 3.3% | 0.6% |
| 5.9% | 11.7% | 10.5% | 9.2% | 7.7% | 5.9% |
| 6.9% | 14.7% | 13.7% | 12.7% | 11.5% | 10.2% |
| 7.9% | 17.3% | 16.5% | 15.6% | 14.7% | 13.6% |
| 8.9% | 19.7% | 19.0% | 18.3% | 17.5% | 16.6% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.26
Low vs growth
Net debt
$6.9B
Total debt − cash
Beta
0.47
Vs market benchmark
Frequently asked questions
Zimmer Biomet Holdings (ZBH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation